XFOR
X4 Pharmaceuticals, Inc
NASDAQ · Healthcare · Biotechnology · US
$3.58
+2.29%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 37.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.28x
- Price / sales
- 22.40x
- Price / cash flow
- -4.24x
Enterprise value
- Enterprise value
- $224.2M
- EV / sales
- 14.15x
- EV / EBITDA
- -2.82x
- EV / EBIT
- -2.55x
- Market cap
- $354.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026